The largest database of trusted experimental protocols

P maleimidophenyl isocyanate

Manufactured by Merck Group
Sourced in United Kingdom

P-maleimidophenyl isocyanate is a chemical compound used in various laboratory applications. It is a reactive compound that can be utilized in organic synthesis and bioconjugation reactions. The core function of this product is to facilitate the attachment of chemical moieties or biomolecules through its reactive isocyanate and maleimide functional groups.

Automatically generated - may contain errors

2 protocols using p maleimidophenyl isocyanate

1

Hydroxyapatite Surface Functionalization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hydroxyapatite (20 µm, ⩾97%, synthetic), (3-mercaptopropyl) triethoxysilane (MPTES) (⩾95%), Propan-2-ol (puriss, p.a., ACS reagent, ⩾99.8% (GC)), HCl (ACS reagent, 37%), potassium hydroxide (reagent grade, 90%), mEthanol (CHROMASOLV®, ⩾99.9%), p-maleimidophenyl isocyanate (PMPI) (purum, ⩾97%) and sodium borohydride (NaBH4) (99.99% trace metals basis) were acquired from Sigma-Aldrich Ltd (UK). Ethanol (absolute, analytical reagent grade), dimethyl sulfoxide (DMSO) (analytical reagent grade) and Ellman’s reagent (5,5′-Dithio-bis-(2-nitrobenzoic acid)) were acquired from Fisher Scientific (UK). Acheson Silver DAG was acquired from Agar Scientific (UK). VICTREX® PEEK™ 450PF (25 µm, easy fine flow) was acquired from Victrex plc (UK). Kapton® polyimide film was acquired from DuPont™ (USA). Loctite® Frekote® 44-NC mould release agent was acquired from Henkel (Germany). Distilled water acquired from an arium® advance EDI pure water system by Sartorius (Germany).
+ Open protocol
+ Expand
2

Synthesis and Characterization of CBT-Maleimide Conjugate

Check if the same lab product or an alternative is used in the 5 most similar protocols
17.5 mg of 6-amino-2-cyanobenzothiazole (CBT, Sigma) (0.1 mmol) and 10.7 mg of p-maleimidophenyl isocyanate (Sigma) (0.05 mmol) were dissolved in 1 mL of anhydrous dimethyl sulfoxide and stirred for 30 min at room temperature. The product was purified by preparative high-performance liquid chromatography (HPLC) on an Agilent 1260 Infinity system equipped with a Supelcosil PLC-18 12 μm, 250 × 21.2 mm column. The mobile phase consisted of 0.1% formic acid in H2O (buffer A), and 0.1% formic acid in acetonitrile (buffer B). A gradient from 5 to 95% of buffer B in buffer A was run over 30 min at a flow rate of 5 mL min−1. The separation was monitored at 335 nm. The identity of the product was confirmed by mass spectrometry (MS) and nuclear magnetic resonance (NMR) (Supplementary Fig. 1a, b).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!